Mental Health

Innovation in Women’s Mental Health

At the start of each week we share a quick “best of” from the week that was with our Inner Circle members. What’s trending in the Femtech Insider community and beyond? We’ve got you covered! In this week’s brief we talk about… Spotlight: Mental Health Tech Virtual Panel: Marketing & Advocating for Femtech Brands in Times of Ad Bans & Stigmatization Startup Spotlight: Hormonella, FemXX Health & BabyFORTE…

Meela Picks Up €400K; Launches Its Therapist-Patient Matchmaking Platform for Women

Therapist-patient matchmaking platform Meela was founded by Tiffany Boswell and Natali Suo with the mission to help women find their best-fit therapist from day 1. Today the team launches the platform, that has already served 400 beta-users and announces a €400K funding round. Investors in this round include Annika Sten Pärson and Per-Jörgen Pärson from The Inner Foundation, Kerstin Cooley and Katja…

Beauty Brand No7 and Hypnotherapy App Clementine Partner to Launch a New Offer for Menopausal Women 

No7, a skin care brand popular in the UK, is teaming up with Clementine, a women’s wellness focused hypnotherapy app. The two companies have teamed up and created six free to access mind-skin rituals for women going through menopause to help them feel more in control of their day and their skin. These new digital rituals work in tandem with the new…

Behavioral Health Startup Brave Health Partners with The Doula Network to Improve Maternal Mental Health in Medicaid Populations

Brave Health, a virtual-first behavioral health provider focused on serving Medicaid populations, today announced a new partnership with The Doula Network (TDN), a Medicaid provider committed to improving access to doula care and expanding reimbursement for doula services. The collaboration seeks to address the maternal and mental health disparities that disproportionately affect women in underserved communities. Postpartum depression and anxiety are the leading complication…

Healthline Media and BEAM Announce Black Trans Women’s Wellness and Mental Health Grants

Healthline Media in partnership with the Black Emotional and Mental Health Collective (BEAM) has announced the Black Trans Women’s Wellness and Mental Health Grants. The new program will award three grants of up to $10K each to Black trans women-led projects that support Black trans women’s mental health. Applications are now open, and winners will be announced in January 2022. The grants are part…

HEAL Launches Its Digital Support Platform for Survivors of Sexual Abuse

HEAL Innovations, a company empowering survivors of sexual abuse to overcome their past and reclaim their lives, today announced the launch of its digital healing service website. Founder Wendy M. Johnson HEAL’s Founder Wendy M. Johnson is the author the HEAL Curriculum, an educational 14-session curriculum for survivors to go through. The company was incubated in the Harvard Innovation Labs – Venture…

Virtual Eating Disorder Clinic Equip Expands Geographically and Now Reaches Half the U.S. Population

Equip, a leading provider of virtual, evidence-based eating disorder treatment in the U.S., today announced the expansion of its services into four major markets – Colorado, Florida, Georgia, and Illinois. With this growth, Equip is now able to serve half the country – over 160 million patients and their families – through Family-Based Treatment (FBT) delivered at home for lasting recovery. “We’ve long known how widespread…

Field Trip Pursues Postpartum Depression and Treatment Resistant Depression as Lead Indications for FT-104, Its Novel Psychedelic Compound

Field Trip, a leader in the development and delivery of psychedelic therapies, has announced the lead indications for FT-104, its novel psychedelic compound in development, will be Treatment Resistant Depression (TRD) and Postpartum Depression (PPD). Through Field Trip Discovery, its drug development division, Field Trip is developing next-generation psychedelic molecules. Its first molecule in development, FT-104, a prodrug, is a synthetic serotonin-2A…